tomeko

Lissencephaly type 1 due to doublecortin gene mutation

Just diagnosed with Lissencephaly type 1 due to doublecortin gene mutation?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Lissencephaly type 1 due to doublecortin gene mutation, look for clinical trials, and connect with others living with it — all in one place.

Open the full Lissencephaly type 1 due to doublecortin gene mutation hub →

Overview

Lissencephaly type 1 due to doublecortin gene mutation is a rare condition. Also known as X-linked lissencephaly type 1. Tomeko brings together the specialists, research, clinical trials, treatments and community for Lissencephaly type 1 due to doublecortin gene mutation so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:2148 · OMIM 300067 · ICD-10 Q04.3 · GARD 0006914

Find care for Lissencephaly type 1 due to doublecortin gene mutation

Authoritative references for Lissencephaly type 1 due to doublecortin gene mutation

Common questions

I was just diagnosed with Lissencephaly type 1 due to doublecortin gene mutation — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Lissencephaly type 1 due to doublecortin gene mutation, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Lissencephaly type 1 due to doublecortin gene mutation?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Lissencephaly type 1 due to doublecortin gene mutation, filtered to your area.

Are there clinical trials for Lissencephaly type 1 due to doublecortin gene mutation?

Tomeko shows live, recruiting studies for Lissencephaly type 1 due to doublecortin gene mutation from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com